Monday, 25 June 2018｜Source：CHINA CHAMBER OF COMMERCEFOR IMPORT&EXPORT OF MEDICINES &HEALTH PRODUCTS｜Author：
On June 20, the 18th CPhI China, the 6th ICSE China & NEX China 2018 as well as P-MEC China 2018 is staged in Shanghai New Int'l Expo Centre (SNIEC). The exhibition is organized by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), and co-organized by UBM Sinoexpo. This year, CPhI China and its co-located events will cover an area of 180,000㎡, with more than 3,000 exhibitors from home and abroad and more than 60,000 domestic and overseas visitors to join the great event of the pharmaceutical industry.
On June 20, the 18th CPhI China, the 6th ICSE China & NEX China 2018 as well as P-MEC China 2018 is staged in Shanghai New Int'l Expo Centre (SNIEC). The exhibition is organized by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), and co-organized by UBM Sinoexpo. This year, CPhI China and its co-located events will cover an area of 180,000㎡, with more than 3,000 exhibitors from home and abroad and more than 60,000 domestic and overseas visitors to join the great event of the pharmaceutical industry.
Mr. John van der Valk said, in the last few years the return of trained scientists from overseas had fuelled an increasingly active R&D community – no other country had come close to matching this recent rate of R&D advancement. Couple this with regulatory changes, and there is a clear opportunity to launch products in China – and at much faster rate than ever before possible. “But it’s not just the new-found market access efficiency that is behind this surge of interest. It is the collective environment that has evolved, as harmonisation with global standards accelerates. For example, in the last year, China has joined the ICH and grown the CFDA’s investigational capabilities exponentially. It’s a truly frenetic rate of development and, it is therefore in no way surprising just how quickly we are seeing increased domestic international partnerships established – many of which will begin here this week.”, he said.
Mr. Zhou Hui, Mr. John van der Valk, Mr. Jime Essink, CEO of UBM Asia, Mr. Zhang Wei, Secretary General of Chinese Pharmacopoeia Commission, Mr. Xu Xingfeng, Deputy Special Commissioner of Shanghai Special Commissioner’s Office of Ministry of Commerce of China, Mr. Jerome Lepentre, Minister Counselor for Health and Consumers, Delegation of the European Commission in Beijing, Mr. Liu Fuxue, Deputy Director of China International Import Expo Bureau, Vice President of National Exhibition and Convention Center(Shanghai) Co., Ltd., Mr. Wang Qiang, Chairman of the board of Shanghai East Best & Lansheng International (Group) Co. Ltd., Mr. Alexey Alekhin，Head of Department of pharmaceutical and medical industry development，Ministry of Industry and Trade of the Russian Federation, Mr. Mazin M. AL Ismaiel，Executive Director of Public Relations， Saudi Food Drug Authority, Mrs. Caroline Larsen Le Tarnec，Head of Public Relations & Documentation Division，European Directorate for the Quality of Medicines & HealthCare (EDQM, Council of Europe), Mr. Hideo Tsunoda, Chairman of Japan Pharmaceutical Traders' Association, Mr. Oh Jang Suk, Chairman of Korea Pharmaceutical Traders Association, Ms. Kang Wei, Managing Director of China Association of Enterprises with Foreign, Investment, R&D-based Pharmaceutical Association Committee, Mr. Zhu Lihong, Senior Vice President and Managing Director, DIA Greater China attended the opening ceremony and cut the ribbon for the exhibition.
Distinguished guests from Royal Embassy of Saudi Arabia, China’s National Drug Administration, and Shanghai Municipal Food and Drug Administration, Provincial Commerce Department and those from other government bodies also attended the opening ceremony.
This year’s exhibition introduced new country pavilions from Poland, Russia and Brazil, joining India and South Korea, as well as an entirely new co-located event in Pharma Excipients. Series of meetings and forums will also be held during the exhibition period, covering how international companies can expand activities in China, and also address the needs of Chinese companies who are looking to grow operations internationally.
